Prevalence and factors associated with telogen effluvium in adult females at Makkah region, Saudi Arabia: A retrospective study

Fatani, Mohammad I.; Mahfoz, Ahmed M. Bin; Mahdi, A.H.; Al-Afif, Khalid A.; Hussain, Waleed A.; Khan, Abdulmajeed; Banjar, Adel

doi:10.1016/j.jdds.2014.04.002

Cited by 16 publications

(15 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In our study 63.3% subjects had hair loss persisting for more than 6 months and hence would be categorised under chronic diffuse telogen hair loss. Similar finding is reported in a study by Fatani M I et al where 79.2% of telogen effluvium patients had hair loss persisting for more than 6 months and only 20.8% of patients had acute telogen effluvium [13]. Chronic diffuse telogen hair loss can be idiopathic, nutritional or even female pattern hair loss.…”

Section: Discussionsupporting

confidence: 88%

A Study to Evaluate the Efficacy of Baicapil Formulations in Treatment of Telogen Effluvium

2018

IJCED

View full text Add to dashboard Cite

Introduction:The changes in lifestyle and food habits have resulted in a steady increase in number of people presenting with hair loss and poses quite a challenge for dermatologists. Baicalin is an active flavonoid which activates dermal papilla cells & induces the mRNA expression of growth factors, such as insulin like growth factor 1 (IGF1) and vascular endothelial growth factor (VEGF). This action can clinically transform the telogen phase to anagen phase due to which there is good scope of using this product in telogen effluvium. Materials & Methods:This was a pilot study on 30 subjects who had persistent hair loss for more than 3 months. Subjects were directed to apply 1ml (6 sprays) of the anti hair loss serum containing Baicapil in the morning after bath & once before bed time for 2 months. Efficacy of the hair serum was assessed using subjective scale and objective method at baseline, day 30 and day 60. Results:In our study 63.3% of subjects had persistent hair loss of more than 6 months duration. Majority of our subjects belonged to the age group of 21 to 25 years with mean age of 26.33 ± 8.7 years and 46.7% were students. In the study median subjective score at 1st visit was 7, at 2 nd visit score reduced to 6 and at 60 th day score reduced to 4 which is statistically significant (p=<0.001). With respect to objective assessment at Point A, median number of thin hairs at 1 st visit was 6, at 2 nd visit it reduced to 4 and at 3 rd visit reduced to 3. With respect to Objective assessment in Point B, median number of thin hairs at 1st visit was 5, at 2 nd visit reduced to 3 and at 3 rd visit reduced to 2 which was also statistically significant(p=<0.001). Conclusion:Baicapil formulations are effective in decreasing hair loss and promoting hair growth in case of patients with telogen effluvium. Volume 3 | Issue 2 | 1 of 5

show abstract

Section: Discussionsupporting

confidence: 88%

A Study to Evaluate the Efficacy of Baicapil Formulations in Treatment of Telogen Effluvium

2018

IJCED

View full text Add to dashboard Cite

show abstract

“…Among the 84 patients of TE in our study, as also in a South Arabian one, its peak incidence (47, 56%) was during the third decade of life [ 7 ]. For unknown reasons, chronic TE seems to affect only women [ 7 ]. History of hair coming out along with the bulbs given by 74 (88.1%) of our 84 patients of TE was statistically significant ( p = 0.00, strength of association, χ 2 = 24.180); 10 (11.09%) of these developed it after pregnancy; 58 (69.1%) underwent a period of stress during the preceding six months and 53 (65.1%) were vegetarians.…”

Section: Discussionmentioning

confidence: 88%

“…Telogen effluvium in women commonly occurs during the age of 30–60 years, usually commencing abruptly with or without a recognizable initiating factor [ 7 ]. Among the 84 patients of TE in our study, as also in a South Arabian one, its peak incidence (47, 56%) was during the third decade of life [ 7 ]. For unknown reasons, chronic TE seems to affect only women [ 7 ].…”

Section: Discussionmentioning

confidence: 99%

“…History of hair coming out along with the bulbs given by 74 (88.1%) of our 84 patients of TE was statistically significant ( p = 0.00, strength of association, χ 2 = 24.180); 10 (11.09%) of these developed it after pregnancy; 58 (69.1%) underwent a period of stress during the preceding six months and 53 (65.1%) were vegetarians. Positive hair pull test in all scalp areas indicative of associated TE was detected in 46 (54.8%) of these 84 cases; the Saudi Arabian study reported positive hair pull test in 61% of their cases of TE [ 7 ]. Sixty-three (75%) of our 84 patients of TE were anemic (Hb < 12 gm%) and 8 (9.5%) were iron deficient (serum ferritin < 12 μ g/L).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function

Deo

Wadhokar

Tyagi

2016

Dermatology Research and Practice

View full text Add to dashboard Cite

Alopecia can either be inherited or acquired; the latter, more common, can be diffuse, patterned, and focal, each having cicatricial and noncicatricial forms. This observational study of 135 cases in a semiurban Indian population aimed to detect the prevalence of various forms of acquired alopecia in females and correlate the same with levels of hemoglobin, serum ferritin, triiodothyronine, thyroxin, and thyroid stimulating hormone. The majority (84, 62.2%) of our cases of alopecia had telogen effluvium followed by female pattern alopecia (32, 23.7%). Stress (86, 63.7%), topical application of chemicals (72, 53.3%), systemic medications for concurrent illnesses (62, 5%), and pregnancy (14, 10.3%) were the common exacerbating factors. Neither low hemoglobin (<12 gm%, 73.4%) nor low serum ferritin (<12 μg/L, 6.7%) was found to be statistically significant. A majority (90, 90.9%) of 99 cases with anemia (hemoglobin levels of <12 gm%) had serum ferritin levels >12 μg/L. Though lack of vitamin B12 testing was a limitation of our study, its deficiency could be the probable cause of iron deficiency as the majority (58, 64.4%) of these cases, as indeed majority (89, 65.4%) of our study population, were vegetarians. Thyroid disorders (23, 17%, including 9 newly diagnosed) were not of significance statistically.

show abstract

“…The study conducted by Thomas et al [8] found that the patients with AA in their study ranged between 20 to 40 years. Telogen effluvium was prevalent between 15 to 20 years, however in the study conducted by Fatani et al [9] it was found between 21 to 40 years. Androgenetic alopecia was found between 26 to 30 years; Quan et al [10] found its prevalence between 31 and 35 years.…”

Section: Discussionmentioning

confidence: 82%

Estimation of Serum Ferritin Levels in Patients with Various Forms of Alopecia: A Case-Control Study

Pokhrel¹,

Parajuli²,

Shah³

et al. 2016

AIMDR

View full text Add to dashboard Cite

Background:Hair is considered as one of the most essential feature of human appearance. It is an ectodermal structure with no vital function, yet its cosmetic and emotional significance is enormous, as is evident from the distress of losing hair. It is a widespread hitch affecting up to 50 percent of males and females during their lives. The most commonly accepted causes of hair loss include nutritional deficiencies, particularly that of iron. Hair loss could also be a sign of underlying systemic illness like anemia, hypothyroidism, hyperthyroidism, chronic infectious diseases, etc. Serum ferritin is directly related to intracellular ferritin and thus to total body iron stores. Iron deficiency results in low serum ferritin concentrations. The association of low serum ferritin level with hair loss has been a controversial topic over the years. Hence, the present study was conducted to measure the serum ferritin level in various types of alopecia and comparison with controls. Objectives: To measure the serum ferritin level in various types of non-cicatricial alopecia and comparison with controls. Methods: This study was conducted on 100 non-cicatricial alopecia patients reporting to the Department of Dermatology, Nepalgunj Medical College and Teaching Hospital, Nepalgunj, Nepal for the period of one year from May 2014 to June 2015. All study participants were enrolled after a detailed medical history and clinical examination by the same experienced dermatologist to rule out conditions that can cause hair loss. In addition to clinical examination, the baseline investigations including, haemoglobin level, ESR and serum ferritin levels were also carried out. Serum ferritin was measured by standard enzyme-linked immunosorbent assay (ELISA) method. The lower reference limit of serum ferritin taken in this study was 40 ng/ml. The statistical analysis was done using student 't' test for the difference of means and chi-square test for ratios. The p-value of <0.05 was taken to be significant. Results: Out of 100 cases, 80% were that of alopecia areata, followed by 12% of telogen effluvium and 8% of androgenetic alopecia. Amongst 100 patients of alopecia, alopecia areata was observed in 21-25 years of age group (25%); telogen effluvium was found between 15-20 year age group (41.7%) and androgenetic alopecia was seen most commonly in the 26-30 year age group (50%). Alopecia areata and telogen effluvium were found more in female patients (82.5% and 91.7%, respectively) where as androgenetic alopecia was observed mainly in males (62.5). An extremely significant difference (p<0.001) in the mean serum ferritin levels was seen in the cases (68±41.89 ng/ml) and controls (26.37±16.01 ng/ml). The mean ferritin levels of patients with alopecia areata (59.46±53.37 ng/ml) and androgenetic alopecia (114.88±58.15 ng/ml) were significantly higher than that in the controls (p<0.0001), whereas the mean ferritin level of patients with telogen effluvium (29.67±14.14 ng/ml) was not significantly different from that of controls (p=0.49). Conclus...

show abstract

Prevalence and factors associated with telogen effluvium in adult females at Makkah region, Saudi Arabia: A retrospective study

Cited by 16 publications

References 21 publications

A Study to Evaluate the Efficacy of Baicapil Formulations in Treatment of Telogen Effluvium

A Study to Evaluate the Efficacy of Baicapil Formulations in Treatment of Telogen Effluvium

Clinicoepidemiological Observational Study of Acquired Alopecias in Females Correlating with Anemia and Thyroid Function

Estimation of Serum Ferritin Levels in Patients with Various Forms of Alopecia: A Case-Control Study

Contact Info

Product

Resources

About